In vitro and in vivo bioluminescent imaging of hypoxia in tissue-engineered grafts

Tissue Engineering - Part C: Methods

Volumn 16, Issue 3, 2010, Pages 479-485

  Liu, Jun ^a   Barradas, Ana ^a   Fernandes, Hugo ^a   Janssen, Frank ^a   Papenburg, Bernke ^a   Stamatialis, Dimitrios ^a   Martens, Anton ^b   Van Blitterswijk, Clemens ^a   De Boer, Jan ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS; BIOREACTORS; ENZYME ACTIVITY; NUTRIENTS; OXYGEN; PLANTS (BOTANY); TISSUE ENGINEERING;

CELL CULTURE MEDIUMS; FLOW PERFUSION BIOREACTOR; IN-VITRO; LUCIFERASE ACTIVITIES; LUCIFERASE GENES; NUTRIENT AVAILABILITY; NUTRIENT DIFFUSION; REPORTER SYSTEMS; STATIC CULTURE; SURVIVAL AND GROWTH; TISSUE-ENGINEERED CONSTRUCTS; TISSUE-ENGINEERED GRAFTS; TRANSGENIC CELLS; VERSATILE TOOLS;

CELL CULTURE;

MUS;

LUCIFERASE;

ANIMAL; ANOXIA; ARTICLE; BIOREACTOR; CHO CELL; CRICETULUS; CULTURE MEDIUM; GENETICS; HAMSTER; HUMAN; IN VITRO STUDY; TISSUE ENGINEERING; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANOXIA; BIOREACTORS; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA; HUMANS; LUCIFERASES; TISSUE ENGINEERING;

EID: 77952921857     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2009.0278     Document Type: Article

References (40)

1. Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249, 2000.
2. Griffith, C.K., Miller, C., Sainson, R.C., Calvert, J.W., Jeon, N.L., Hughes, C.C., and George, S.C. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 11, 257, 2005.
3. Ishaug-Riley, S.L., Crane-Kruger, G.M., Yaszemski, M.J., and Mikos, A.G. Three-dimensional culture of rat calvarial os-teoblasts in porous biodegradable polymers. Biomaterials 19, 1405, 1998.
4. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., and Vunjak-Novakovic, G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Bio-technol Bioeng 93, 332, 2006.
5. Malda, J., Woodfield, T.B., van der Vloodt, F., Kooy, F.K., Martens, D.E., Tramper, J., van Blitterswijk, C.A., and Riesle, J. The effect of PEGT=PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Bio-materials 25, 5773, 2004.
6. Rivron, N.C., Liu, J.J., Rouwkema, J., de Boer, J., and van Blitterswijk, C.A. Engineering vascularised tissues in vitro. Eur Cell Mater 15, 27, 2008.
7. Druecke, D., Langer, S., Lamme, E., Pieper, J., Ugarkovic, M., Steinau, H.U., and Homann, H.H. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A 68, 10, 2004.
8. Martin, I., Wendt, D., and Heberer, M. The role of bioreac-tors in tissue engineering. Trends Biotechnol 22, 80, 2004.
9. Wendt, D., Stroebel, S., Jakob, M., John, G.T., and Martin, I. Uniform tissues engineered by seeding and culturing cells in 3D scaffolds under perfusion at defined oxygen tensions. Biorheology 43, 481, 2006.
10. Rouwkema, J., Rivron, N.C., and van Blitterswijk, C.A. Vascularization in tissue engineering. Trends Biotechnol 26, 434, 2008.
11. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E.S., Kohane, D.S., Darland, D.C., Marini, R., van Blitterswijk, C.A., Mulligan, R.C., D'Amore, P.A., and Langer, R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23, 879, 2005.
12. Roda, A., Guardigli, M., Pasini, P., and Mirasoli, M. Biolu-minescence and chemiluminescence in drug screening. Anal Bioanal Chem 377, 826, 2003.
13. Choy, G., Choyke, P., and Libutti, S.K. Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2, 303, 2003.
14. Luker, G.D., and Luker, K.E. Optical imaging: current applications and future directions. J Nucl Med 49, 1, 2008.
15. de Boer, J., van Blitterswijk, C., and Lowik, C. Biolumines-cent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials 27, 1851, 2006.
16. Malda, J., Klein, T.J., and Upton, Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng 13, 2153, 2007.
17. Harris, A.L. Hypoxia\a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38, 2002.
18. Shibata, T., Giaccia, A.J., and Brown, J.M. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther 7, 493, 2000.
19. Harada, H., Kizaka-Kondoh, S., Itasaka, S., Shibuya, K., Morinibu, A., Shinomiya, K., and Hiraoka, M. The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. Biochem Bio-phys Res Commun 360, 791, 2007.
20. 2 levels and modulate growth factor pathways. Wound Repair Regen 11, 496, 2003.
21. Harada, H., Kizaka-Kondoh, S., and Hiraoka, M. Optical imaging of tumor hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals. Mol Imaging 4, 182, 2005.
22. Chau, N.M., Rogers, P., Aherne, W., Carroll, V., Collins, I., McDonald, E., Workman, P., and Ashcroft, M.Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hyp-oxic stress and growth factors. Cancer Res 65, 4918, 2005.
23. Shibata, T., Akiyama, N., Noda, M., Sasai, K., and Hiraoka, M. Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Int J Radiat Oncol Biol Phys 42, 913, 1998.
24. Yamazaki, Y., Egawa, K., Nose, K., Kunimoto, S., and Ta-keuchi, T. HIF-1-dependent VEGF reporter gene assay by a stable transformantofCHO cells. BiolPharm Bull 26, 417,2003.
25. Siddappa, R., Martens, A., Doorn, J., Leusink, A., Olivo, C., Licht, R., van Rijn, L., Gaspar, C., Fodde, R., Janssen, F., van Blitterswijk, C., and de Boer, J. cAMP=PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 105, 7281, 2008.
26. Janssen, F.W., Oostra, J., Oorschot, A., and van Blitterswijk, C.A. A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials 27, 315, 2006.
27. Papenburg, B.J., Vogelaar, L., Bolhuis-Versteeg, L.A., Lam-mertink, R.G., Stamatialis, D., and Wessling, M. One-step fabrication of porous micropatterned scaffolds to control cell behavior. Biomaterials 28, 1998, 2007.
28. An, W.G., Kanekal, M., Simon, M.C., Maltepe, E., Blago-sklonny, M.V., and Neckers, L.M. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392, 405, 1998.
29. Kellner, K., Liebsch, G., Klimant, I., Wolfbeis, O.S., Blunk, T., Schulz, M.B., and Gopferich, A. Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng 80, 73, 2002.
30. Lewis, M.C., Macarthur, B.D., Malda, J., Pettet, G., and Please, C.P. Heterogeneous proliferation within engineered cartilaginous tissue: the role of oxygen tension. Biotechnol Bioeng 91, 607, 2005.
31. Guarino, R.D., Dike, L.E., Haq, T.A., Rowley, J.A., Pitner, J.B., and Timmins, M.R. Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration. Biotechnol Bioeng 86, 775, 2004.
32. Olivo, C., Alblas, J., Verweij, V., van Zonneveld, A.J., Dhert, W.J., and Martens, A.C. In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells. J Orthop Res 26, 901, 2008.
33. Brown, D.A., MacLellan, W.R., Laks, H., Dunn, J.C., Wu, B.M., and Beygui, R.E. Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. Bio-technol Bioeng 97, 962, 2007.
34. 2 tension. Am J Physiol 271, C1172, 1996.
35. Radisic, M., Deen, W., Langer, R., and Vunjak-Novakovic, G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 288, H1278, 2005.
36. Khattak, S.F., Chin, K.S., Bhatia, S.R., and Roberts, S.C. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng 96, 156, 2007.
37. Hung, S.C., Pochampally, R.R., Hsu, S.C., Sanchez, C., Chen, S.C., Spees, J., and Prockop, D.J. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2, e416, 2007.
38. Inoue, Y., Izawa, K., Tojo, A., Sekine, R., Okubo, T., and Ohtomo, K. Light emission requires exposure to the atmosphere in ex vivo bioluminescence imaging. Mol Imaging 5, 53, 2006.
39. Moriyama, E.H., Niedre, M.J., Jarvi, M.T., Mocanu, J.D., Moriyama, Y., Subarsky, P., Li, B., Lilge, L.D., and Wilson, B.C. The influence of hypoxia on bioluminescence in lucif-erase-transfected gliosarcoma tumor cells in vitro. Photo-chem Photobiol Sci 7, 675, 2008.
40. Klerk, C.P., Overmeer, R.M., Niers, T.M., Versteeg, H.H., Richel, D.J., Buckle, T., Van Noorden, C.J., and van Tell-ingen, O. Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques 43 (1 Suppl), 7, 2007.